CIK 0001831828
- Large accelerated filer
Vera Therapeutics, Inc.
Sign in to watch- Ticker
- VERA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812744449
- Phone
- +1 650-770-0077
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,334,142
- in 2 filings, $1.3M under 10b5-1 plans
Net −$1,334,142. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-07 | Fordyce Marshall President and CEO | Option exercise | +6,785 | $2.90 | $20K | 187,935 |
| 2022-09-07 | Fordyce Marshall President and CEO | Sale | −6,785 | $20.03 | $136K | 181,150 |
| 2022-09-07 | Fordyce Marshall President and CEO | Option exercise · Stock Option (Right to Buy) | −6,785 | 1,049,131 | ||
| 2022-09-07 | Curley Joanne Chief Development Officer | Sale | −988 | $18.63 | $18K | 28,797 |
| 2022-09-02 | Fordyce Marshall President and CEO | Option exercise | +7,346 | $2.90 | $21K | 188,496 |
| 2022-09-02 | Fordyce Marshall President and CEO | Sale | −7,346 | $20.26 | $149K | 181,150 |
| 2022-09-02 | Fordyce Marshall President and CEO | Option exercise | +9,750 | $2.90 | $28K | 190,900 |
| 2022-09-02 | Fordyce Marshall President and CEO | Sale | −9,750 | $21.50 | $210K | 181,150 |
| 2022-09-02 | Fordyce Marshall President and CEO | Option exercise · Stock Option (Right to Buy) | −17,096 | 1,055,916 | ||
| 2022-09-01 | Fordyce Marshall President and CEO | Option exercise | +17,100 | $2.90 | $50K | 198,250 |
| 2022-09-01 | Fordyce Marshall President and CEO | Sale | −17,100 | $21.22 | $363K | 181,150 |
| 2022-09-01 | Fordyce Marshall President and CEO | Option exercise · Stock Option (right to buy) | −17,100 | 1,073,012 | ||
| 2022-08-22 | Curley Joanne Chief Development Officer | Option exercise | +1,030 | $11.00 | $11K | 30,815 |
| 2022-08-22 | Curley Joanne Chief Development Officer | Sale | −1,030 | $18.42 | $19K | 29,785 |
| 2022-08-22 | Curley Joanne Chief Development Officer | Option exercise | +600 | $11.00 | $7K | 30,385 |
| 2022-08-22 | Curley Joanne Chief Development Officer | Sale | −600 | $19.65 | $12K | 29,785 |
| 2022-08-22 | Curley Joanne Chief Development Officer | Option exercise · Stock Options (right to buy) | −1,630 | 102,917 | ||
| 2022-08-19 | Curley Joanne Chief Development Officer | Grant or award | +12,500 | 29,785 | ||
| 2022-08-19 | Curley Joanne Chief Development Officer | Option exercise | +378 | $6.37 | $2K | 30,163 |
| 2022-08-19 | Curley Joanne Chief Development Officer | Sale | −378 | $18.89 | $7K | 29,785 |
Page 23 of 30 · 581 trades